✦ LIBER ✦

Effects of chronic monoamine oxidase inhibitor treatment on biogenic amine metabolism in rat brain

✍ Scribed by D.S. Robinson; I.C. Campbell; Margaret Walker; Nancy J. Statham; W. Lovenberg; D.L. Murphy

Book ID: 118953958
Publisher: Elsevier Science
Year: 1979
Tongue: English
Weight: 598 KB
Volume: 18
Category: Article
ISSN: 0028-3908
DOI: 10.1016/0028-3908(79)90021-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Reserpine, monoamine oxidase inhibitors,

Reserpine, monoamine oxidase inhibitors, and distribution of biogenic amines in monkey brain

✍ Gordon R. Pscheidt; Harold E. Himwich 📂 Article 📅 1963 🏛 Elsevier Science 🌐 English ⚖ 506 KB

BW 1370U87, a new monoamine oxidase-A in

BW 1370U87, a new monoamine oxidase-A inhibitor: Effects on biogenic amine neurotransmitter and metabolite levels in rat brain

✍ Stacey A. Jones-Humble; Ron M. Norton; Helen L. White; Barrett R. Cooper 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 424 KB

Effect of some monoamine oxidase inhibit

Effect of some monoamine oxidase inhibitors on deamination of biogenic monoamines by rat liver mitochondrial monoamine oxidase

✍ V. Z. Gorkin; L. I. Gridneva; L. B. Klyashtorin; I. V. Veryovkina; I. Vina 📂 Article 📅 1966 🏛 Springer 🌐 English ⚖ 107 KB

Effect of acrylamide on biogenic amine l

Effect of acrylamide on biogenic amine levels, monoamine oxidase, and cathepsin D activity of rat brain

✍ Rakesh Dixit; Rausan Husain; Hasan Mukhtar; Prahlad K. Seth 📂 Article 📅 1981 🏛 Elsevier Science 🌐 English ⚖ 346 KB

Effect of Rhazya stricta Decne on Monoam

Effect of Rhazya stricta Decne on Monoamine Oxidase and Cholinesterase Activity and Brain Biogenic Amine Levels in Rats

✍ B. H. ALI; M. O. M. TANIRA; A. K. BASHIR; A. A. AL-QARAWI 📂 Article 📅 2000 🏛 Pharmaceutical Press 🌐 English ⚖ 77 KB

Effects of pyrroxan and chlordiazepoxide

Effects of pyrroxan and chlordiazepoxide on biogenic amine metabolism in the rat brain

✍ T. A. Pugsley; W. Lippmann 📂 Article 📅 1976 🏛 Springer 🌐 English ⚖ 631 KB

Pyrroxan (20 mg/kg, i.p.) , a new potential antianxiety agent, increased brain norepinephrine (NE) turnover in rats, reflecting a possible central e-adrenergic receptor blocking activity, in contrast, chlordiazepoxide (20 mg/kg, i.p.), a widely used antianxiety agent, did not alter the NE turnover.